These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 28076436)
1. Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer. Vitali F; Cohen LD; Demartini A; Amato A; Eterno V; Zambelli A; Bellazzi R PLoS One; 2017; 12(1):e0170363. PubMed ID: 28076436 [TBL] [Abstract][Full Text] [Related]
2. A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer. Vitali F; Cohen LD; Demartini A; Amato A; Eterno V; Zambelli A; Bellazzi R PLoS One; 2016; 11(9):e0162407. PubMed ID: 27632168 [TBL] [Abstract][Full Text] [Related]
4. Correction: The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer. Fatima I; El-Ayachi I; Taotao L; Angeles Lillo M; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA PLoS One; 2018; 13(5):e0197796. PubMed ID: 29771986 [TBL] [Abstract][Full Text] [Related]
5. Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Hamy AS; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F PLoS One; 2016; 11(7):e0159123. PubMed ID: 27388624 [TBL] [Abstract][Full Text] [Related]
6. Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis. Giudici F; Petracci E; Nanni O; Bottin C; Pinamonti M; Zanconati F; Scaggiante B PLoS One; 2019; 14(12):e0227068. PubMed ID: 31856204 [TBL] [Abstract][Full Text] [Related]
7. Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial. Jank P; Gehlhaar C; Lederer B; Fontanella C; Schneeweiss A; Karn T; Marmé F; Sinn HP; van Mackelenbergh M; Sinn B; Zahm DM; Ingold-Heppner B; Schem C; Stickeler E; Fasching PA; Nekljudova V; Taube ET; Heppner F; Müller V; Denkert C; Loibl S PLoS One; 2021; 16(9):e0257142. PubMed ID: 34469495 [TBL] [Abstract][Full Text] [Related]
8. Correction: Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer. Wang L; Xiao Y; Ping Y; Li J; Zhao H; Li F; Hu J; Zhang H; Deng Y; Tian J; Li X PLoS One; 2019; 14(8):e0221483. PubMed ID: 31415668 [TBL] [Abstract][Full Text] [Related]
9. Correction: galectin-3 as a marker and potential therapeutic target in breast cancer. PLOS ONE Staff PLoS One; 2015; 10(1):e0116994. PubMed ID: 25621883 [TBL] [Abstract][Full Text] [Related]
10. Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. Dotan I; Roche PJ; Tamilia M; Paliouras M; Mitmaker EJ; Trifiro MA PLoS One; 2016; 11(6):e0158022. PubMed ID: 27309538 [TBL] [Abstract][Full Text] [Related]
11. Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery. Bromberg SE; Moraes PRAF; Ades F PLoS One; 2018; 13(3):e0195130. PubMed ID: 29579107 [TBL] [Abstract][Full Text] [Related]
12. Correction: A Multi-Methodological MR Resting State Network Analysis to Assess the Changes in Brain Physiology of Children with ADHD. Alonso Bde C; Tobón SH; Suarez PD; Flores JG; Carrillo Bde C; Pérez EB PLoS One; 2015; 10(11):e0143785. PubMed ID: 26599279 [TBL] [Abstract][Full Text] [Related]
13. Correction: Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction. Vijayasarveswari V; Andrew AM; Jusoh M; Ahmad RB; Sabapathy T; Raof RAA; Yasin MNM; Khatun S; Rahim HA PLoS One; 2021; 16(5):e0251679. PubMed ID: 33956904 [TBL] [Abstract][Full Text] [Related]
14. Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer. Zhang H; Luo M; Liang X; Wang D; Gu X; Duan C; Gu H; Chen G; Zhao X; Zhao Z; Liu C PLoS One; 2020; 15(4):e0232166. PubMed ID: 32298386 [TBL] [Abstract][Full Text] [Related]
15. Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome. Syed BM; Morgan D; Setty T; Green AR; Paish EC; Ellis IO; Cheung KL PLoS One; 2018; 13(1):e0191979. PubMed ID: 29370282 [TBL] [Abstract][Full Text] [Related]
16. Correction: 3, 3'5 Triiodo L Thyronine Induces Apoptosis in Human Breast Cancer MCF-7cells, Repressing SMP30 Expression through Negative Thyroid Response Elements. Sar P; Peter R; Rath B; Mohapatra AD; Mishra SK PLoS One; 2013; 8(6):. PubMed ID: 29294469 [TBL] [Abstract][Full Text] [Related]
17. Correction: Genetic dissection of main and epistatic effects of QTL based on augmented triple test cross design. Zhang X; Sun C; Zhang Z; Dai Z; Chen Y; Yuan X; Yuan Z; Tang W; Li L; Hu Z PLoS One; 2018; 13(5):e0198562. PubMed ID: 29847579 [TBL] [Abstract][Full Text] [Related]
18. Correction: Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing. PLOS Computational Biology Staff PLoS Comput Biol; 2017 Jan; 13(1):e1005312. PubMed ID: 28045897 [TBL] [Abstract][Full Text] [Related]
19. Correction: Treating Depressive Symptoms in Psychosis: A Network Meta-Analysis on the Effects of Non-Verbal Therapies. Steenhuis LA; Nauta MH; Bockting CLH; Pijnenborg GHM PLoS One; 2018; 13(12):e0209762. PubMed ID: 30566532 [TBL] [Abstract][Full Text] [Related]
20. Correction: In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer. Miyazaki R; Anayama T; Hirohashi K; Okada H; Kume M; Orihashi K PLoS One; 2016; 11(11):e0166505. PubMed ID: 27824955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]